Anjum, S;
Fourkala, EO;
Zikan, M;
Wong, A;
Gentry-Maharaj, A;
Jones, A;
Hardy, R;
... Widschwendter, M; + view all
(2014)
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.
Genome Med
, 6
(6)
47 -.
10.1186/gm567.
Preview |
PDF
gm567.pdf Download (1MB) |
Abstract
BRCA1 mutation carriers have an 85% risk of developing breast cancer but the risk of developing non-hereditary breast cancer is difficult to assess. Our objective is to test whether a DNA methylation (DNAme) signature derived from BRCA1 mutation carriers is able to predict non-hereditary breast cancer.
Archive Staff Only
View Item |